You are here

  • Home
  • Online First
  • Beta blocker versus ivabradine for cardiovascular outcomes among patients with atrial fibrillation

Article info

Article menu
Download PDFPDF
Original research
Beta blocker versus ivabradine for cardiovascular outcomes among patients with atrial fibrillation

Authors

  • Wei Syun Hu School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanDivision of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Cheng Li Lin School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Wei Syun Hu, Division of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital 2, Yuh-Der Road, Taichung 40447, Taiwan; WEISYUNHU{at}GMAIL.COM
View Full Text

Citation

Hu WS, Lin CL
Beta blocker versus ivabradine for cardiovascular outcomes among patients with atrial fibrillation
Postgraduate Medical Journal Published Online First: 22 August 2022. doi: 10.1136/pmj-2022-141948

Publication history

  • Received May 24, 2022
  • Accepted July 30, 2022
  • First published August 22, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.